Partnering with Metabian
Your product. New markets. One trusted Irish partner.
If you are a pharmaceutical manufacturer in the European Union, Canada or the United States looking to extend the reach of your portfolio, Metabian offers a proven, low-risk route. We in-license your product, obtain its marketing authorisation, complete its registration, and market it responsibly in the territories we serve — protecting your product’s reputation and your standards at every step. As an Irish company, we act solely in the interest of the products we carry.
Who we partner with
Manufacturers looking for reach
- Originator manufacturers with medicines approaching or beyond patent expiry seeking wider market reach.
- Generic and value-added manufacturers seeking a registration and commercialisation partner in new territories.
- Licensors and authorisation holders seeking a reliable Irish European counterpart.
- Manufacturers across the EU, Canada and the USA looking for a single accountable route to new markets.
Our in-licensing model
How it works
Five stages, from the licence to the market and everything that follows it.
- 01
Sourcing & in-licensing
We identify medicinal products that fit our therapeutic focus and secure the licensing rights.
- 02
Marketing authorisation
We prepare and manage the regulatory submissions required to obtain authorisation in each target territory.
- 03
Product registration
We complete the registration processes that make each product legally available on the market.
- 04
Commercialisation & market access
We bring the product to market and represent it professionally in the territories we operate in.
- 05
Lifecycle & compliance
We maintain authorisations, manage variations, and uphold pharmacovigilance and quality obligations throughout the product's life.
- ManufacturerYour product, your standards
- In-LicenceWe secure the rights
- AuthorisationWe obtain the MA
- RegistrationWe make it legally available
- MarketWe commercialise and maintain it
What Metabian takes on
So you don't have to
- Regulatory strategy and submissions
- Marketing-authorisation applications and holding
- National product registration
- Pharmacovigilance and safety obligations
- Import, distribution and market-access coordination
- Commercialisation and portfolio representation
- Lifecycle management and variations
Partnership models
The shapes an agreement can take
In-licensing agreements
For products entering the markets we serve.
Marketing-authorisation holding & representation
Acting as your authorisation counterpart.
Distribution & commercialisation agreements
Bringing your product to market.
Territory-based exclusive partnerships
Structured to fit your objectives.
What you gain
Why manufacturers choose this route
- Access to new international markets without establishing your own local entity
- A single accountable partner from licence to market
- Deep focus across nine therapeutic areas and a one-stop portfolio approach
- Regulatory and registration expertise in the markets we serve
- Long-term, transparent collaboration and responsible product stewardship
Our partnering process
From first conversation to ongoing stewardship
- 01
Initial contact & confidentiality
We discuss your product and objectives under NDA.
- 02
Evaluation & fit
We assess the product against our therapeutic focus and market needs.
- 03
Proposal & agreement
We define territory, model and commercial terms.
- 04
Regulatory & registration execution
We obtain the authorisations and complete registration.
- 05
Launch & commercialisation
We bring the product to market.
- 06
Ongoing stewardship
Lifecycle, compliance and performance management.
